BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 6088974)

  • 21. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
    Raina V; Williams CJ; Gurtoo HL
    Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that Benzo(a) pyrene-resistant, aryl hydrocarbon hydroxylase-deficient variants of mouse hepatoma line, Hepa-1, are mutational in origin.
    Hankinson O
    Somatic Cell Genet; 1981 Jul; 7(4):373-88. PubMed ID: 6269236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenobiotic metabolism and mutation in a human lymphoblastoid cell line.
    Crespi CL; Altman JD; Marletta MA
    Chem Biol Interact; 1985 May; 53(3):257-71. PubMed ID: 4006009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
    Mason ME; Okey AB
    Cancer Res; 1981 Jul; 41(7):2778-82. PubMed ID: 6265068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism.
    Crespi CL; Thilly WG
    Mutat Res; 1984 Sep; 128(2):221-30. PubMed ID: 6088974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of liver cell cultures in mutagenesis studies.
    Huberman E; Jones CA
    Ann N Y Acad Sci; 1980; 349():264-72. PubMed ID: 6784635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of enzymatic DNA repair in carcinogenesis and cancer chemotherapy].
    Harbers E
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1978 Aug; 92(1):1-9. PubMed ID: 151399
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.